This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Institute of Materia Medica, Cas. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Yangliang Ye: Innovator in Pharmaceutical Chemistry
Introduction
Yangliang Ye is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Yangliang Ye holds a patent for "Pyrimidinyl-propionic acid derivatives and their use as PPAR agonists." This invention discloses compounds of Structural Formula (I), including enantiomers, racemic bodies, pharmaceutically acceptable salts, solvates, or hydrates. The compounds are designed to activate PPAR-RXR heterodimers, which interact with specific DNA response elements within the promoter regions of target genes. This innovation is particularly relevant for the treatment and prevention of polycystic kidney disease and cancer.
Career Highlights
Yangliang Ye is affiliated with the Shanghai Institute of Materia Medica, where he conducts research and development in medicinal chemistry. His work has led to advancements in understanding how specific compounds can influence biological pathways.
Collaborations
Some of his notable coworkers include Jianhua Shen and Changlin Mei, who have collaborated with him on various research projects.
Conclusion
Yangliang Ye's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work holds promise for developing new treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile